Trial Profile
YM150 Long Term Study - Long-Term Study in Patients With a History of Venous Thromboembolism.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Jan 2011
Price :
$35
*
At a glance
- Drugs Darexaban (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
- Focus Registrational; Therapeutic Use
- 05 Jan 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 05 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Jan 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.